All Stories

  1. High Somatic Mutation and Neoantigen Burden Do Not Correlate with Decreased Progression-Free Survival in HCC Patients not Undergoing Immunotherapy
  2. Updates on the Role of Molecular Alterations and NOTCH Signalling in the Development of Neuroendocrine Neoplasms
  3. Updates on the Role of Molecular Alterations and NOTCH Signaling in the Development of Neuroendocrine Neoplasms
  4. Cancer Diagnostic and Predictive Biomarkers 2018
  5. Unique true predicted neoantigens (TPNAs) correlates with anti-tumor immune control in HCC patients
  6. The Role of Sensing Peptides in the Cross-talk between Microbiota and Human Cancer Cells
  7. Prevalence of “unclassified” HPV genotypes among women with abnormal cytology
  8. Cancer Vaccine for HCC
  9. Human Oncoviruses and p53 Tumor Suppressor Pathway Deregulation at the Origin of Human Cancers
  10. HepaVac-101 first-in-man therapeutic cancer vaccine phase I/II clinical trial for hepatocellular carcinoma patients.
  11. Distinct profiles of TERT promoter mutations and telomerase expression in head and neck cancer and cervical carcinoma
  12. Large deletion at the CDC73 gene locus and search for predictive markers of the presence of a CDC73 genetic lesion
  13. P-G5 Differential immune response to HCV peptides as cancer-progression biomarkers of HCV-infections
  14. The Role of Circulating Free DNA and MicroRNA in Non-Invasive Diagnosis of HBV- and HCV-Related Hepatocellular Carcinoma
  15. Cellular prognostic markers in hepatitis-related hepatocellular carcinoma
  16. Telomerase promoter mutations in human immunodeficiency virus-related conjunctiva neoplasia
  17. Cell Penetrating Peptides as Molecular Carriers for Anti-Cancer Agents
  18. Sex Hormone Receptors in Benign and Malignant Salivary Gland Tumors: Prognostic and Predictive Role
  19. Immunotherapy in ovarian, endometrial and cervical cancer: State of the art and future perspectives
  20. New Insights in the Design of Bioactive Peptides and Chelating Agents for Imaging and Therapy in Oncology
  21. New vaccination strategies in liver cancer
  22. New cell block containing agarose for cytopathological diagnosis of tumor samples
  23. Accuracy of Fine Needle Cytology in Histological Prediction of Papillary Thyroid Carcinoma Variants: a Prospective Study
  24. Use of adjuvants for immunotherapy
  25. Frequency and geographic distribution of TERT promoter mutations in primary hepatocellular carcinoma
  26. An Overview of Bioactive Peptides for in vivo Imaging and Therapy in Human Diseases
  27. An Engineered Cell-Instructive Stroma for the Fabrication of a Novel Full Thickness Human Cervix Equivalent In Vitro
  28. Comparative analysis of HPV16 gene expression profiles in cervical and in oropharyngeal squamous cell carcinoma
  29. TERT promoter and CTNNB1 gene mutations represent cancer signatures specific for hepatitis B and hepatitis C related hepatocellular carcinoma
  30. MDM2 gene polymorphisms and risk of classic Kaposi’s sarcoma among Iranian patients
  31. Cancer Diagnostic and Predictive Biomarkers 2016
  32. Virus-Like Particles
  33. Vaccine Approaches in Hepatocellular Carcinoma
  34. Discovery to first-in-man studies of a multi-peptide-based hepatocellular carcinoma vaccine adjuvanted with CV8102 (RNAdjuvant) – HEPAVAC
  35. Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial
  36. Immunological effects of a novel RNA-based adjuvant in liver cancer patients
  37. Abstract A046: Identification and validation of HCC-specific gene transcriptional signature for tumor antigen discovery
  38. Abstract A044: Immunological effects of a novel RNA-based adjuvant in liver cancer patients
  39. Tumor specific mutations in TERT promoter and CTNNB1 gene in hepatitis B and hepatitis C related hepatocellular carcinoma
  40. Identification and Validation of HCC-specific Gene Transcriptional Signature for Tumor Antigen Discovery
  41. Variability in Immunohistochemical Detection of Programmed Death Ligand 1 (PD-L1) in Cancer Tissue Types
  42. Detection of human papillomavirus DNA in peri-tumor tissues and pelvic lymph nodes as potential molecular marker of micrometastasis in cervical cancer
  43. Combinatorial immunotherapy strategies for hepatocellular carcinoma
  44. Cancer vaccines for hepatocellular carcinoma: future directions
  45. Candidate Soluble Immune Mediators in Young Women with High-Risk Human Papillomavirus Infection: High Expression of Chemokines Promoting Angiogenesis and Cell Proliferation
  46. Molecular alterations in hepatocellular carcinoma associated with hepatitis B and hepatitis C infections
  47. CXCR4/CXCL12/CXCR7 axis is functional in neuroendocrine tumors and signals on mTOR
  48. A novel multi-drug metronomic chemotherapy significantly delays tumor growth in mice
  49. Infectious Agents and Cancer reviewer acknowledgement 2015
  50. A-108 Viral and cellular biomarkers in HPV-related cancers
  51. Functional characterization of biodegradable nanoparticles as antigen delivery system
  52. Systems Biology Approach for Cancer Vaccine Development and Evaluation
  53. Developments in cancer vaccines for hepatocellular carcinoma
  54. An overview of new biomolecular pathways in pathogen-related cancers
  55. Cancer biomarkers
  56. Cellular prognostic markers in hepatocellular carcinoma
  57. Identification of a distinct population of CD133+CXCR4+ cancer stem cells in ovarian cancer
  58. Brooke-Spiegler syndrome presenting multiple concurrent cutaneous and parotid gland neoplasms: Cytologic findings on fine-needle sample and description of a novel mutation of the CYLD gene
  59. Correction: Genetic Diversity of the KIR/HLA System and Susceptibility to Hepatitis C Virus-Related Diseases
  60. Novel metronomic chemotherapy and cancer vaccine combinatorial strategy for hepatocellular carcinoma in a mouse model
  61. Tobacco Smoke Activates Human Papillomavirus 16 p97 Promoter and Cooperates with High-Risk E6/E7 for Oxidative DNA Damage in Lung Cells
  62. Combined Papillary and Mucoepidermoid Carcinoma of the Thyroid Gland: a Possible Collision Tumor Diagnosed on Fine-Needle Cytology. Report of a Case with Immunocytochemical and Molecular Correlations
  63. Primary Peritoneal Clear Cell Carcinoma Versus Ovarian Carcinoma Versus Malignant Transformation of Endometriosis
  64. Detection of high mobility group A2 specific mRNA in the plasma of patients affected by epithelial ovarian cancer
  65. Genetic Diversity of the KIR/HLA System and Susceptibility to Hepatitis C Virus-Related Diseases
  66. Follicular thyroid carcinoma with skull metastases
  67. Update on Head and Neck Cancer: Current Knowledge on Epidemiology, Risk Factors, Molecular Features and Novel Therapies
  68. Cancer Diagnostic and Predictive Biomarkers 2015
  69. Identification of Human Herpesvirus 8 Sequences in Conjunctiva Intraepithelial Neoplasia and Squamous Cell Carcinoma of Ugandan Patients
  70. The XIX century smallpox prevention in Naples and the risk of transmission of human blood-related pathogens
  71. Virus-like Particles
  72. HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2
  73. CXCR4 expression affects overall survival of HCC patients whereas CXCR7 expression does not
  74. Antigen-specific vaccines for cancer treatment
  75. Borderline Brenner tumor of the ovary: a case report with immunohistochemical and molecular study
  76. TP53 and PIK3CA gene mutations in adenocarcinoma, squamous cell carcinoma and high-grade intraepithelial neoplasia of the cervix
  77. HPV-related oropharyngeal cancers: From pathogenesis to new therapeutic approaches
  78. Formation of self-assembled triple-layered rotavirus-like particles (tlRLPs) by constitutive co-expression of VP2, VP6, and VP7 in stably transfected high-five insect cell lines
  79. Systems vaccinology for cancer vaccine development
  80. 150 Carcinogenesis of HPV
  81. Human Papillomavirus Infection and Cervical Neoplasia among Migrant Women Living in Italy
  82. Emotional false memories in children with learning disabilities
  83. CDK/CCN and CDKI Alterations for Cancer Prognosis and Therapeutic Predictivity
  84. The Functional Role of MnSOD as a Biomarker of Human Diseases and Therapeutic Potential of a New Isoform of a Human Recombinant MnSOD
  85. Developments in virus-like particle-based vaccines for HIV
  86. Duodenal gangliocytic paraganglioma, a rare entity among GEP-NET: a case report with immunohistochemical and molecular study
  87. Cancer Diagnostic and Predictive Biomarkers
  88. Electrochemotherapy as “new standard of care” treatment for cutaneous Kaposi's sarcoma
  89. Corrigendum to: “Challenges in cancer vaccine development for hepatocellular carcinoma” [J Hepatol 2013;59:897–903]
  90. Prediction of individual immune responsiveness to a candidate vaccine by a systems vaccinology approach
  91. Virus-like particle vaccines for the prevention of human papillomavirus infection
  92. Cancer-Associated CD43 Glycoforms as Target of Immunotherapy
  93. Challenges in cancer vaccine development for hepatocellular carcinoma
  94. VLPs and particle strategies for cancer vaccines
  95. New developments in cancer vaccines
  96. Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections
  97. Kaposi’s sarcoma: Etiology and pathogenesis, inducing factors, causal associations, and treatments: Facts and controversies
  98. High HMGA2 expression and high body mass index negatively affect the prognosis of patients with ovarian cancer
  99. Infections and cancer: debate about using vaccines as a cancer control tool
  100. Development of a stable insect cell line constitutively expressing rotavirus VP2
  101. Mutations of the TP53 gene in adenocarcinoma and squamous cell carcinoma of the cervix: A systematic review
  102. Molecular Signatures Associated with HCV-Induced Hepatocellular Carcinoma and Liver Metastasis
  103. Developments in virus-like particle-based vaccines for HIV
  104. The application of virus-like particles to human diseases
  105. Lung cancer diagnosis on ovary mass: a case report
  106. Massive edema of ovary with cytogenetic alteration of chromosome 12q13-15 in adolescent patient: a case report
  107. Expression Analysis of SPARC/Osteonectin in Oral Squamous Cell Carcinoma Patients: From Saliva to Surgical Specimen
  108. Viral and Cellular Biomarkers in the Diagnosis of Cervical Intraepithelial Neoplasia and Cancer
  109. Characterization of humoral responses to soluble trimeric HIV gp140 from a clade A Ugandan field isolate
  110. Somatic mutations of STK11 gene in human papillomavirus positive and negative penile cancer
  111. Identification and sequence analysis of a novel human leukocyte antigen alleleB*51:141
  112. Oncolytic virus therapies
  113. Multiparametric Analyses of Human PBMCs Loaded Ex Vivo with a Candidate Idiotype Vaccine for HCV-Related Lymphoproliferative Disorders
  114. HIV p24 as Scaffold for Presenting Conformational HIV Env Antigens
  115. Immunogenomics approaches for vaccine evaluation
  116. Functional Interaction between Human Papillomavirus Type 16 E6 and E7 Oncoproteins and Cigarette Smoke Components in Lung Epithelial Cells
  117. Advances in viral oncology research: summary of the 3rd International Meeting
  118. Immunogenicity of HIV Virus-Like Particles in Rhesus Macaques by Intranasal Administration
  119. Characterization of the Human Papillomavirus (HPV) Integration Sites into Genital Cancers
  120. Quality of life, lifestyle behavior and employment experience: A comparison between young and midlife survivors of gynecology early stage cancers
  121. Axillary node metastasis from differentiated thyroid carcinoma with hürthle and signet ring cell differentiation. A case of disseminated thyroid cancer with peculiar histologic findings
  122. Molecular epidemiology of human herpesvirus 8 variants in Kaposi's sarcoma from Iranian patients
  123. Effects of adjuvants on IgG subclasses elicited by virus-like Particles
  124. HPV type distribution in invasive cervical cancers in Italy: pooled analysis of three large studies
  125. Innate immunity and hepatitis C virus infection: a microarray’s view
  126. Assessment ofChlamydia trachomatisinfection among Eastern European and West African women immigrants in South Italy
  127. Developments in virus-like particle-based vaccines for infectious diseases and cancer
  128. Plant-derived anti-HIV-1 proteins
  129. Dendritic cells in the pathogenesis and treatment of human diseases: a Janus Bifrons?
  130. Can HIV p24 Be a Suitable Scaffold for Presenting Env Antigens?
  131. PlantPIs – An Interactive Web Resource on Plant Protease Inhibitors
  132. Generation of HIV-1 Virus-Like Particles expressing different HIV-1 glycoproteins
  133. HIV-Gag VLPs presenting trimeric HIV-1 gp140 spikes constitutively expressed in stable double transfected insect cell line
  134. High prevalence of human papillomavirus infection in Eastern European and West African women immigrants in South Italy
  135. New adjuvants in evolving vaccine strategies
  136. Human papillomavirus (HPV) genotypes and HPV16 variants and risk of adenocarcinoma and squamous cell carcinoma of the cervix
  137. TP53 and MDM2 gene polymorphisms and risk of hepatocellular carcinoma in Italian patients
  138. Systems biology applied to vaccine and immunotherapy development
  139. Metastatic breast carcinoma to parathyroid adenoma on fine needle cytology sample: Report of a case
  140. Translating Tumor Antigens into Cancer Vaccines
  141. MDM2 and CDKN1A gene polymorphisms and risk of Kaposi’s sarcoma in African and Caucasian patients
  142. Immune Signatures and Systems Biology of Vaccines
  143. Constitutive expression of HIV-VLPs in stably transfected insect cell line for efficient delivery system
  144. Prevalence of Human Papillomavirus Types in High-Grade Cervical Intraepithelial Neoplasia and Cancer in Italy
  145. Plant-based anti-HIV-1 strategies: vaccine molecules and antiviral approaches
  146. Human papillomavirus infection in urine samples from male renal transplant patients
  147. Virus-Like Particles as Particulate Vaccines
  148. Human herpesvirus type 8 variants circulating in Europe, Africa and North America in classic, endemic and epidemic Kaposi's sarcoma lesions during pre-AIDS and AIDS era
  149. Immune signatures in human PBMCs of idiotypic vaccine for HCV-related lymphoproliferative disorders
  150. FEZ1/LZTS1 protein expression in ovarian cancer
  151. Conformational HIV-1 Envelope on particulate structures: a tool for chemokine coreceptor binding studies
  152. Virus-like particle vaccines and adjuvants: the HPV paradigm
  153. Adhesion molecules and p16 expression in endocervical adenocarcinoma
  154. Molecular immune signatures of HIV-1 vaccines in human PBMCs
  155. Short Communication: Limited Induction of IL-10 in PBMCs from HIV-Infected Subjects Treated with HIV-VLPs
  156. Molecular and phylogenetic analysis of HIV-1 variants circulating in Italy
  157. Fine-needle cytology of metastatic endometrioid neoplasms: Experience with eight cases
  158. Detection of mucosal and cutaneous human papillomaviruses in oesophagitis, squamous cell carcinoma and adenocarcinoma of the oesophagus
  159. Unsung Hero Robert C. Gallo
  160. Spontaneous infarction of pleomorphic adenoma: Report of a case simulating malignancy on fine-needle cytology sample
  161. Sclerosing polycystic adenosis of the parotid gland: Report of one case diagnosed by fine-needle cytology with in situ malignant transformation
  162. Gene profiling, biomarkers and pathways characterizing HCV-related hepatocellular carcinoma
  163. P12-03. Generation of novel recombinant HIV-1 glycoproteins for expression on virus like particles
  164. P19-11. Generation of virus-like particles expressing different HIV-1 glycoproteins for induction of broadly neutralizing antibodies
  165. TP53 Codon 72 Polymorphism in Classic, Endemic and Epidemic Kaposi’s Sarcoma in African and Caucasian Patients
  166. A pilot study on the distribution of human papillomavirus genotypes and HPV-16 variants in cervical neoplastic lesions from Ecuadorian women
  167. Th2 Polarization in Peripheral Blood Mononuclear Cells from Human Immunodeficiency Virus (HIV)-Infected Subjects, as Activated by HIV Virus-Like Particles
  168. Analysis of TP53 codon 72 polymorphism in HPV-positive and HPV-negative penile carcinoma
  169. Human papillomavirus (HPV) genotypes and HPV16 variants in human immunodeficiency virus-positive Italian women
  170. Translational fusion of chloroplast-expressed human papillomavirus type 16 L1 capsid protein enhances antigen accumulation in transplastomic tobacco
  171. Clear-cell myoepithelial carcinoma of the salivary glands: A clinicopathologic, immunohistochemical, and ultrastructural study of two cases involving the submandibular gland with review of the literature
  172. Correction
  173. Gene expression profile of peripheral blood mononuclear cells in response to HIV-VLPs stimulation
  174. Molecular and phylogenetic analysis of HIV-1 variants circulating in Italy
  175. HIV Type 1 Subtype A Epidemic in Injecting Drug User (IDU) Communities in Iran
  176. DNA–VLP prime–boost intra-nasal immunization induces cellular and humoral anti-HIV-1 systemic and mucosal immunity with cross-clade neutralizing activity
  177. Human Immunodeficiency Virus Type 1 Subtype Distribution in the Worldwide Epidemic: Pathogenetic and Therapeutic Implications
  178. Human papillomavirus genotypes and HPV16 variants in penile carcinoma
  179. Genetic and phylogenetic evolution of HIV-1 in a low subtype heterogeneity epidemic: the Italian example
  180. Genetic and Phylogenetic Characterization of Structural Genes from Non-B HIV-1 Subtypes in Italy
  181. Baculovirus-Derived Human Immunodeficiency Virus Type 1 Virus-Like Particles Activate Dendritic Cells and Induce Ex Vivo T-Cell Responses
  182. Evaluating the role of human papillomaviruses in conjunctival neoplasia
  183. Prevalence of alpha-papillomavirus genotypes in cervical squamous intraepithelial lesions and invasive cervical carcinoma in the Italian population
  184. Induction of Systemic and Mucosal Cross-Clade Neutralizing Antibodies in BALB/c Mice Immunized with Human Immunodeficiency Virus Type 1 Clade A Virus-Like Particles Administered by Different Routes of Inoculation
  185. Evaluation of a modified version of Heteroduplex Mobility Assay for rapid screening of HIV-1 isolates in epidemics characterized by mono/dual clade predominance
  186. TP53 codon 72 polymorphism and risk of conjunctival squamous cell carcinoma in Uganda
  187. Screening of HIV-1 Isolates by Reverse Heteroduplex Mobility Assay and Identification of Non-B Subtypes in Italy
  188. Human papillomaviruses and cervical lesions in the Italian population
  189. Analysis of human papillomavirus type-16 variants in Italian women with cervical intraepithelial neoplasia and cervical cancer
  190. Kaposi's sarcoma: aetiopathogenesis, histology and clinical features
  191. Induction of neutralizing antibodies and cytotoxic T lymphocytes in Balb/c mice immunized with virus-like particles presenting a gp120 molecule from a HIV-1 isolate of clade A
  192. High efficient production of Pr55gag virus-like particles expressing multiple HIV-1 epitopes, including a gp120 protein derived from an Ugandan HIV-1 isolate of subtype A
  193. Identification and functional analysis of sequence rearrangements in the long control region of human papillomavirus type 16 Af-1 variants isolated from Ugandan penile carcinomas
  194. The Uganda study on HPV variants and genital cancers
  195. Warthin-like tumour of the thyroid gland: RET/PTC expression indicates it is a variant of papillary carcinoma
  196. Sequence Note: A Novel Glycoprotein 120 Sequence from an HIV Type 1 Isolate of the A Clade Identified in North Uganda
  197. Sequence variations and viral genomic state of human papillomavirus type 16 in penile carcinomas from Ugandan patients.
  198. Post-operative complications after completion thyroidectomy for differentiated thyroid cancer
  199. Herpesvirus-like DNA sequences detected in endemic, classic, iatrogenic and epidemic Kaposi's sarcoma (KS) biopsies
  200. Analysis of HIV-1 env gene V3 loop sequence in a southern Italian cohort of intravenous drug users
  201. Human Immunodeficiency Virus Type 1 tat Gene Enhances Human Papillomavirus Early Gene Expression
  202. Human papillomavirus (hpv) DNA in penile carcinomas and in two cell lines from high-incidence areas for genital cancers in Africa
  203. Role of HIV as Cofactor in HPV Oncogenesis: In vitro Evidences of Virus Interactions
  204. Role of HIV-1 Tat in the Pathogenesis of AIDS-Associated Kaposi�s Sarcoma1
  205. V3 Region Genotyping of HIV Isolates in Northern Uganda: Heteroduplex Mobility Assay, Nucleotide Sequence and Phylogenese Analysis